Turner N, Saura C, Aftimos P, van den Tweel E, et al. Trastuzumab Duocarmazine in Pretreated Human Epidermal Growth Factor Receptor 2-Positive Advanced or Metastatic Breast Cancer: An Open-Label, Randomized, Phase III Trial (TULIP). J Clin Oncol 2024 Oct 23:JCO2400529. doi: 10.1200/JCO.24.00529.
PMID: 39442070